Page 2 - Pharma Stocks
Lupin share falls over 2% as USFDA issues 3 observations for Pithampur unit
Lupin share price fell after the United States Food and Drug Administration (USFDA) issued 3 observations for its Pithampur Unit-1, based in Madhya Pradesh.
 "Lupin share falls over 2% as USFDA issues 3 observations for Pithampur unit")
Sun Pharma gains 3%; hits new high on UBS 'Buy' rating, sees more upside
UBS has a target price of Rs 2,450 on Sun Pharma and expects it to record the highest growth in the near-term and the medium-term via a ramp-up of the specialty drug pipelline.
 "Sun Pharma gains 3%; hits new high on UBS 'Buy' rating, sees more upside")
SeQuent Scientific jumps 18% after announcing merger with Viyash Life
The company said the proposed merger is expected to be Ebitda margin accretive and deleverage SeQuent's balance sheet.fle
 "SeQuent Scientific jumps 18% after announcing merger with Viyash Life")
UBS fears slowdown in India, US pharma markets; gives 'Sell' on 4 stocks
As per UBS, the Indian pharma market is slowing down due to a sharp increase in unbranded generics
 "UBS fears slowdown in India, US pharma markets; gives 'Sell' on 4 stocks")
AstraZeneca Pharma receives nod for cancer drug Durvalumab; stock soars 12%
The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL sol from CDSO.
 "AstraZeneca Pharma receives nod for cancer drug Durvalumab; stock soars 12%")
Nifty Pharma, FMCG indices range-bound; Check support and other levels here
The Nifty Pharma Index is currently trading in a defined range between 23,700 and 22,700. This suggests that the market is experiencing indecision, with neither buyers nor sellers dominating.
 "Nifty Pharma, FMCG indices range-bound; Check support and other levels here")
Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others
Lupin is preparing the launch of PredForte, having a market of $200 million with 180 days competitive generic therapy (CGT) exclusivity in the near term
 "Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others")
Jhunjhunwala Portfolio: This pharma stock has zoomed over 100% in 6 months
Shares of Jubilant Pharmova surged 12 per cent on the BSE in Friday's intra-day trade to hit a new high of Rs 1,169.55, in an otherwise subdued market.
 "Jhunjhunwala Portfolio: This pharma stock has zoomed over 100% in 6 months")
Panacea Biotec gets $20 mn loan from US DFC for capex; stock rises 5%
The shares of Panacea Biotec rose after the company announced that it has secured $20 million in loan from US International Development Finance Corp (DFC).
 "Panacea Biotec gets $20 mn loan from US DFC for capex; stock rises 5%")
Granules tanks 16% on concerns over 6 observations issued by US FDA
More than 31 million equity shares, representing 12.89 per cent equity of the pharmaceutical company, had changed hands on the NSE till 02:08 PM.
 "Granules tanks 16% on concerns over 6 observations issued by US FDA")
EU GMP Certification sends this small-cap pharma stock flying over 14%
Shares of pharmaceutical company, Medicamen Biotech have advanced 16.15 per cent in the last one week, and 20 per cent in the last one month
 "EU GMP Certification sends this small-cap pharma stock flying over 14%")
This SME stock has surged 61% in 12 days; zoomed 328% in 3 months
Shares of Sudarshan Pharma Industries were frozen in upper circuit of 5 per cent at Rs 274.50, which is also the new high it hit on the BSE in Thursday's intra-day trade.
 "This SME stock has surged 61% in 12 days; zoomed 328% in 3 months")
Pharma stocks soar 6% as investors respond to double dose of Good News!
Individually, shares of Laurus Labs rose up to 5.55 per cent at Rs 517.90 per share, Akums Drugs and Pharmaceuticals shares locked in 5 per cent upper circuit at Rs 910.55 a piece
 "Pharma stocks soar 6% as investors respond to double dose of Good News!")
Panacea Biotec freezes in 10% upper circuit; stock zooms 101% in 1 month
A combined 2.1 million equity shares of the company had changed hands till 02:50 PM, and there are pending buy orders for nearly 100,000 shares on the NSE and BSE.
 "Panacea Biotec freezes in 10% upper circuit; stock zooms 101% in 1 month")
Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'
Antique Broking is bullish on Concord's business model, new launches and niche products
 "Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'")
Natco Pharma rises 4% after filing ANDA for generic lung cancer drug
Natco Pharma is the first company to have filed a substantially complete ANDA for a generic cancer drug
 "Natco Pharma rises 4% after filing ANDA for generic lung cancer drug")
USFDA approval sends this multibagger pharma stock to 52-week high
Northward surge in the stock price is attributed to the news that the company has received approval from the US Food and Drug Administration (USFDA) for its product, 'Bortezomib Injection NDA 212782
 "USFDA approval sends this multibagger pharma stock to 52-week high")
Wanbury jumps 4% after firm gets zero form 483 observations from USFDA
Shares of pharma company Wanbury climbed nearly 4 per cent on Friday after the company received an EIR with zero form 483 observations, from the USFDA
 "Wanbury jumps 4% after firm gets zero form 483 observations from USFDA")
Aarti Drugs surges 13% as board mulls share buyback on August 26
Going ahead in FY25, the management anticipates an improvement in margins, mostly driven by an anticipated growth in export sales and backward integration.
 "Aarti Drugs surges 13% as board mulls share buyback on August 26")
Pfizer surges 3% as investors cheer 350% dividend announcement; details
The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24
